Literature DB >> 8157888

[The possible endometrial risk of ovarian stimulation. Apropos of 3 cases].

E Miannay1, J J Boutemy, M Leroy-Billiard, J P Gasnault, J L Leroy.   

Abstract

Three cases of adenomatous hyperplasia of the endometrium--one of them degenerated--have been reported in young women provided with ovulation stimulation. The association between these hormonal therapies and the adenocarcinoma or its antecedents signs, is particularly disturbing. However, it's difficult to establish a relationship between cause and effect. Indeed the women who suffer from an ovarian sterility are a group exposed to a cancer of the endometrium independently of any other iatrogenic agent. The method of detection is yet to be found, as is the mode of conduct which can reconcile the risk of a carcinoma and the desire of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157888

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  2 in total

Review 1.  Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.

Authors:  Alkistis Skalkidou; Theodoros N Sergentanis; Spyros P Gialamas; Marios K Georgakis; Theodora Psaltopoulou; Marialena Trivella; Charalampos S Siristatidis; Evangelos Evangelou; Eleni Petridou
Journal:  Cochrane Database Syst Rev       Date:  2017-03-25

2.  Fertility drugs and the risk of breast and gynecologic cancers.

Authors:  Louise A Brinton; Vikrant V Sahasrabuddhe; Bert Scoccia
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.